Friday, November 8, 2013

Johnson (and) Johnson to Pay (Dollar) 2.2 Billion to Settle Allegations of Marketing Irregularities

Medindia Health News
Medindia largest health website in india. // via fulltextrssfeed.com 
Helpdesk Ticketing System

Award-winning helpdesk system with an inbuilt KBase, forums, canned responses & more. Try super user friendly Freshdesk today. (In 2 minutes, You'll set it up!)
From our sponsors
Johnson (and) Johnson to Pay (Dollar) 2.2 Billion to Settle Allegations of Marketing Irregularities
Nov 8th 2013, 18:17


The company had been accused of paying incentives to doctors and pharmacies in order to promote three of its medicines, including anti-psychotic drugs Risperdal and Invega and heart drug Natrecor.

The company has also been accused of promoting drugs for uses not officially allowed.

"They lined their pockets at the expense of the American taxpayers, patients and the private insurance industry. They drove up costs for everyone in the healthcare system and negatively impacted the long term solvency of the central healthcare programmes like Medicare", US Attorney General Eric Holder said.

Source: Medindia

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment